The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance
Open accessAbstract
Tumors are not merely masses of neoplastic cells but complex tissues composed of cellular and noncellular elements. This review provides recent data on the main components of a dynamic system, such as carcinoma associated fibroblasts that change the extracellular matrix (ECM) topology, induce stemness and promote metastasis-initiating cells. Altered production and characteristics of collagen, hyaluronan and other ECM proteins induce increased matrix stiffness. Stiffness along with tumor growth-induced solid stress and increased interstitial fluid pressure contribute to tumor progression and therapy resistance. Second, the role of immune cells, cytokines and chemokines is outlined. We discuss other noncellular characteristics of the tumor microenvironment such as hypoxia and extracellular pH in relation to neoangiogenesis. Overall, full understanding of the events driving the interactions between tumor cells and their environment is of crucial importance in overcoming treatment resistance and improving patient outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic of the biomechanical forces in the tumor microenvironment. As tumor cells proliferate they sequentially create new solid material (i.e. cells and matrix components) which generate radial and circumferential solid stresses. In the tumor center, circumferential and radial stresses are compressive while in the periphery, radial stress is compressive and circumferential stress is tensile (direction indicated with arrows). Compressive stresses in the tumor interior squeeze tumor components, including lymphatic and blood vessels (note compressed lumen of blood vessel and high density of cells and extracellular matrix in dark green). After the tumor is cut and the stresses are released, the tumor interior decompresses (note extended lumen of blood vessel, relaxed cells and extracellular matrix in light green). Reproduced and modified with permission from Prof. Rakesh K. Jain [55].](/paper-figures/1194c05f950c4cb6ad9845dd7d769c11/the-role-of-cancer-associated-fibroblasts-solid-stress-and-other-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“fibroblasts respond to a variety of chemotactic signals such as TGF-β, PDGF, and CXCL12, which are differentially distributed within tumors and further drive their directed migration toward tumor cores [286].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [286]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“FSP1 is proangiogenic, possibly mediated either by the activation of plasminogen or through the transcriptional upregulation of MMP13 [68].”
BackgroundKalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“LOXL2 has been reported to be involved in invasiveness [27] and specifically expressed by fibroblasts in tumor tissue [28].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,330
Cited by
Sorted by citations
Items 101–197 of 197
Liu, C., Wang, Y., Kuo, F., Hsu, W., Yu, F., Hsieh, S., Tai, M., Wu, D., & Kuo, C. (2018) · Cancers · doi:10.3390/cancers10120479 · Cited by 23
Glycoprotein asporin as a novel player in tumour microenvironment and cancer progression
Šimková, D., Kharaishvili, G., Slabáková, E., Murray, P. G., & Bouchal, J. (2016) · Biomedical Papers · doi:10.5507/bp.2016.037 · Cited by 23
Self-citationFujita, S., & Ikeda, T. (2016) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2016.09.052 · Cited by 23
Afshar, K., Sanaei, M., Ravari, M. S., Pourbagheri‐Sigaroodi, A., & Bashash, D. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3846 · Cited by 23
Cannon, A. R., Owen, M. K., Guerrero, M. S., Kerber, M. L., Goicoechea, S. M., Hemstreet, K. C., Klazynski, B., Hollyfield, J., Chang, E., Hwang, R. F., et al. (2015) · Cytoskeleton · doi:10.1002/cm.21239 · Cited by 22
Laboratorio de Microambiente Tumoral, C. D. I. B. Y. A. (., Sevic, I., Spinelli, F. M., Laboratorio de Microambiente Tumoral, C. D. I. B. Y. A. (., Cantero, M. J., Instituto de Investigaciones en Medicina Traslacional, F. D. C. B., Reszegi, A., Kovalszky, I., García, M. G., Instituto de Investigaciones en Medicina Traslacional, F. D. C. B., et al. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019.ch2 · Cited by 21
Li, J., Wang, Y., Qin, C., Yao, R., Zhang, R., Wang, Y., Xie, X., Zhang, L. H., Wang, Y., & Ren, Z. (2016) · PubMed Central · Cited by 20
Colucci, R., & Moretti, S. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-2078-z · Cited by 20
Sticz, T. B., Molnár, A., Márk, Á., Hajdú, M., Nagy, N., Végső, G., Micsík, T., Kopper, L., & Sebestyén, A. R. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-203913 · Cited by 19
Paul, J., Yang, C., Wu, H., Tai, A., Dalah, E. Z., Zheng, C., Johnstone, C. A., Kong, F., Gore, E., & Li, X. A. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.02.032 · Cited by 19
High Levels of Hyaluronic Acid Synthase-2 Mediate NRF2-Driven Chemoresistance in Breast Cancer Cells
Choi, B.-H., Ryoo, I.-G., Sim, K. H., Ahn, H.-J., Lee, Y. J., & Kwak, M. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.074 · Cited by 19
Brindisi, M., Frattaruolo, L., Fiorillo, M., Dolce, V., Sotgia, F., Lisanti, M. P., & Cappello, A. R. (2022) · FEBS Journal · doi:10.1111/febs.16651 · Cited by 19
Wang, J., Xu, J., Li, J., Zhao, M., Zhang, H.-F., Liu, D., Zhou, X. M., & Xu, H. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24695 · Cited by 18
Heidary, Z., Ghaisari, J., Moein, S., & Javanmard, S. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232965 · Cited by 18
Im, J., & Nho, R. S. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01529-9 · Cited by 18
Olbromski, M., Mrozowska, M., Piotrowska, A., Smolarz, B., & Romanowicz, H. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03701-w · Cited by 16
Guenther, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1434030 · Cited by 17
Labovsky, V., Martinez, L. M., Calcagno, M. D. L., Davies, K. M., Rivello, H. G., Wernicke, A., Feldman, L. J., Giorello, M. B., Matas, A., Borzone, F. R., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5268-7 · Cited by 17
Ren, T., Sun, L., Zheng, Y., Jiang, Y., Guo, Y., & Ma, J. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002636 · Cited by 20
Ham, J., Wang, B., Po, J. W., Singh, A., Niles, N., & Lee, C. S. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-207357 · Cited by 15
Calvetti, L., Pilotto, S., Carbognin, L., Ferrara, R., Caccese, M., Tortora, G., & Bria, E. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1071350 · Cited by 16
Clemente-Vicario, F., Alvarez, C. E., Rowell, J., Roy, S., London, C. A., Kisseberth, W. C., & Lorch, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142007 · Cited by 15
Palliyage, G. H., Samart, P., Bobbala, S. K. R., Rojanasakul, L. W., Coyle, J. P., Martin, K. H., Callery, P. S., & Rojanasakul, Y. (2023) · Lung Cancer · doi:10.1016/j.lungcan.2023.107258 · Cited by 15
Human Lung Fibroblasts Inhibit Non-Small Cell Lung Cancer Metastasis in Ex Vivo 4D Model
Mishra, D. K., Compean, S. D., Thrall, M. J., Liu, X., Massarelli, E., Kurie, J. M., & Kim, M. P. (2015) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2015.05.014 · Cited by 15
Xin, X., & Yang, S. (2019) · Biochemical Engineering Journal · doi:10.1016/j.bej.2019.05.007 · Cited by 14
Ye, M., Chen, M., Chang, Y., Huang, J., Huang, T., Wong, T., Hong, T.-M., & Chen, Y. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12768 · Cited by 13
Ansaryan, S., Khayamian, M. A., Saghafi, M., Shalileh, S., Nikshoar, M. S., Abbasvandi, F., Mahmoudi, M., Bahrami, F., & Abdolahad, M. (2019) · Advanced Biosystems · doi:10.1002/adbi.201800294 · Cited by 14
A novel method to generate single-cell-derived cancer-associated fibroblast clones
Hashimoto, H., Suda, Y., Miyashita, T., Ochiai, A., Tsuboi, M., Masutomi, K., Kiyono, T., & Ishii, G. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2409-3 · Cited by 12
Oncolytic Viruses as Nanomedicines against the Tumor Microenvironment
Zaheer, U., Hassain, N. A., Banu, S., & Mathew, S. (2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac116.1482514852 · Cited by 12
Scherer, A., Kuhl, S., Wessels, D. J., Lusche, D. F., Hanson, B. M., Ambrose, J., Voss, E. R., Fletcher, E., Goldman, C. D., & Soll, D. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118628 · Cited by 12
Stromal Integrin α11β1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently
Reigstad, I., Smeland, H. Y., Skogstrand, T., Sortland, K., Schmid, M. C., Reed, R. K., & Stuhr, L. E. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151663 · Cited by 12
Koizume, S., & Miyagi, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040809 · Cited by 12
Kamenšek, U., Tešić, N., Serša, G., Kos, Š., & Čemažar, M. (2016) · Plasmid · doi:10.1016/j.plasmid.2016.11.004 · Cited by 11
Mechanomimetic 3D Scaffolds as a Humanized In Vitro Model for Ovarian Cancer
Paradiso, F., Lenna, S., Gazze, S. A., García-Parra, J., Murphy, K., Margarit, L., González, D., Francis, L. W., & Taraballi, F. (2022) · Cells · doi:10.3390/cells11050824 · Cited by 11
Sanz‐Herrera, J. A., Apolinar–Fernández, A., Jimenez-Aires, A., Perez-Alcantara, P., Domínguez, J., & Reina-Romo, E. (2025) · Computers & Structures · doi:10.1016/j.compstruc.2025.107690 · Cited by 10
Kashkooli, F. M., Mirala, F., Tehrani, M. H. H., Alirahimi, M., Souri, M., Golzaryan, A., Kar, S., & Soltani, M. (2025) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.70000 · Cited by 12
RNA-Binding Proteins in Bladder Cancer
Gao, Y., Cao, H., Huang, D., Zheng, L., Nie, Z., & Zhang, S. (2023) · Cancers · doi:10.3390/cancers15041150 · Cited by 10
Matarrese, P., Vona, R., Ascione, B., Cittadini, C., Tocci, A., & Mileo, A. M. (2023) · Cells · doi:10.3390/cells12071048 · Cited by 11
Cassidy, J. W., & Bruna, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804010-2.00004-7 · Cited by 9
Ferrara, B., Bourgoin‐Voillard, S., Habert, D., Vallée, B., Nicolás‐Boluda, A., Simanic, I., Seve, M., Vingert, B., Gazeau, F., Castellano, F., et al. (2024) · PROTEOMICS · doi:10.1002/pmic.202400058 · Cited by 8
Combating chemoresistance: Current approaches & nanocarrier mediated targeted delivery
Shaw, S., Pore, S. K., Liu, D., Kumeria, T., Nayak, R., & Bose, S. K. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189261 · Cited by 9
Gao, C., Liu, F., Ye, Q., & Guo, A. (2023) · Journal of Oncology · doi:10.1155/2023/1424589 · Cited by 8
Instrumental Mechanoreceptoric Palpation in Gastrointestinal Surgery
Solodova, R., Galatenko, V., Nakashidze, E. R., Shapovalyants, S. G., Andreytsev, I. L., Sokolov, M., & Podolskii, V. E. (2017) · Minimally Invasive Surgery · doi:10.1155/2017/6481856 · Cited by 7
Bracigliano, A., Clemente, O., Peddio, A., Scarpati, G. D. V., Pizzolorusso, A., Cannella, L., Picozzi, F., Garosi, C., Papa, F., Balzamo, F., et al. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104852 · Cited by 6
Tumor Interstitial Fluid Promotes Malignant Phenotypes of Lung Cancer Independently of Angiogenesis
Li, H., Li, G., Liu, L., Guo, Z., Ma, X., Cao, N., Lin, H., Han, G., Duan, Y., & Du, G. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0242 · Cited by 6
Hong, S., Balwe, S. G., Samson, A. A. S., & Song, J. M. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102441 · Cited by 5
Yoshida, G. J., Azuma, A., Miura, Y., & Orimo, A. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamb.1.2020.2 · Cited by 5
Feng, J., Sharma, S., Rao, E., Li, X., Zhang, Q., Liao, F., He, J., Han, D. C., & Rao, J. (2019) · Science China Materials · doi:10.1007/s40843-018-9383-3 · Cited by 5
Integrins in cancer: insights into mechanisms and therapeutic potential
Agarwal, P., Raman, R., Agarwal, P., Prabhu, V., & Kumar, P. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02828-w · Cited by 4
Heidary, Z., Javanmard, S. H., Izadi, I., Zare, N., & Ghaisari, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-20634-5 · Cited by 4
Recent Developments in the Study of the Microenvironment of Cancer and Drug Delivery
Chaudhary, B., Kumar, P., Arya, P., Singla, D., Kumar, V., Kumar, D., Roshan, S., Wadhwa, S., Gulati, M., Singh, S. K., et al. (2022) · Current Drug Metabolism · doi:10.2174/1389200224666230110145513 · Cited by 4
The Effect of Stromal Integrin β3-Deficiency on Two Different Tumors in Mice
Reigstad, I., Sortland, K., Skogstrand, T., Reed, R. K., & Stuhr, L. E. B. (2016) · Cancers · doi:10.3390/cancers8010014 · Cited by 4
Una visión integral del cáncer (I). Microambiente tumoral: estudio, clasificación y reprogramación
Noguera, R., Burgos‐Panadero, R., Gamero‐Sandemetrio, E., de la Cruz‐Merino, L., & Naranjo, T. Á. (2019) · Revista Española de Patología · doi:10.1016/j.patol.2018.11.003 · Cited by 6
Liaw, C., Chuang, C., Chang, Y., Liao, T.-Y., Chang, J. W., & Juan, Y. (2017) · Anticancer Research · doi:10.21873/anticanres.12099 · Cited by 4
Nanoparticles and hyperthermia
Neguț, I., & Grumezescu, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816506-5.00012-7 · Cited by 4
Tumor Angiogenesis and Modulators
Xu, K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.95139 · Cited by 3
Ahn, H. S. H., Yazdi, Y. O., Wadsworth, B. J., Bennewith, K. L., Rahmim, A., & Klyuzhin, I. S. (2024) · Cancers · doi:10.3390/cancers16122215 · Cited by 3
Sun, C. (2014) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000190 · Cited by 3
Tong, Y., He, Y., Hu, L., Liu, Y., Zheng, X., Sun, J., Song, Y., Zhang, Y., Fang, L., & Huang, P. C. (2019) · Tumori Journal · doi:10.1177/0300891619871103 · Cited by 3
Prognostic Impact of Stromal Profiles Educated by Gastric Cancer
Takahashi, K., Shoda, K., Takiguchi, K., Higuchi, Y., Matsuoka, K., Nakayama, T., Saito, R., Maruyama, S., Nakata, Y., Furuya, S., et al. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-14522-z · Cited by 3
Qu, Z., & Wang, X. (2026) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203251409639 · Cited by 2
Fu, Y., Huang, Z. Y. X., Huang, J., Xiong, J., Liu, H., & Wan, X. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3568 · Cited by 2
Pathology and Molecular Pathology of Prostate Cancer
Tchrakian, N., Cotter, M. B., & Loda, M. F. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_10 · Cited by 2
Sanz‐Herrera, J. A., Apolinar–Fernández, A., Jimenez-Aires, A., Perez-Alcantara, P., Domínguez, J., & Reina-Romo, E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.09.574800 · Cited by 2
Mechanical Signaling in the Mammary Microenvironment: From Homeostasis to Cancer
Boyle, S. T., Poltavets, V., & Samuel, M. S. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_19 · Cited by 1
Role of Tumor Microenvironment in Hepatocellular Carcinoma Resistance
Akkari, L., & Lujambio, A. (2017) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-56197-4_3 · Cited by 1
Schwint, A. E., Hughes, A. M., Garabalino, M. A., Pozzi, E. C. C., Heber, E. M., & Trivillin, V. A. (2018) · doi:10.1002/9781119275602.ch3.6 · Cited by 1
Palliyage, G. H. (2023) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.12138 · Cited by 1
Estado del arte: metformina, cáncer y leucemia
Ramos-Peñafiel, C. O., Santoyo-Sánchez, A., Olarte-Carrillo, I., Queipo-García, G. E., Garfias, Y., & Martínez‐Tovar, A. (2015) · Revista de Hematología
State of the art: Metformin, cancer and leukemia
Ramos-Peñafiel, C. O., Santoyo-Sánchez, A., Olarte-Carrillo, I., Queipo-García, G. E., Garfias-Becerra, R. Y., & Martínez‐Tovar, A. (2015) · Revista de Hematología
Raykha, C. (2014) · Scholarship@Western (Western University)
Metformina: un arma noble para tiempos más civilizados
Ramos-Peñafiel, C. O., Santoyo-Sánchez, A., Olarte-Carrillo, I., Queipo-García, G. E., Garfias, Y., & Martínez‐Tovar, A. (2015) · Medicina Interna de México
Tumor Stroma, Desmoplasia, and Stromagenesis
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26587-2_185-1
The role of actin networks in cellular mechanosensing
Azatov, M. (2015)
Tumor Blood Vessel-Associated Antigens as Targets for Cancer Immunotherapy
Fabian, K. P. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Jung, Y. H., Park, H., Na, K., Kim, H., Yang, J., & Chung, S. H. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788012683-00294
Exploring the roles of the Protein Kinase N family in breast cancer
Baskaran, P. (2018) · Queen Mary Research Online (Queen Mary University of London)
Tumor Stroma, Desmoplasia, and Stromagenesis
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26956-6_185
Bavle, R. M., & Paremala, K. (2015) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/0973-029x.174648
Extracellular Matrix in Tumor Angiogenesis
Kharaishvili, G. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104661
Self-citationParadiso, F. (2022) · Cronfa (Swansea University) · doi:10.23889/suthesis.60122
Receptor-Specific Radionuclide Therapy
Lepareur, N., & Bourgeois, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_303-1
New Approaches in Gastric Cancer Immunotherapy
Mousavi, P., Ahmadi, A., Behzadifar, S., Mohammadnejad, J., & Hosseini, S. M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005783 · Cited by 1
Jacobs, L., Miller, E. J., Wilson, R. J., Jēčs, E., Tholath, P. J., Nguyen, H. H., Saindane, M., Tahirovic, Y. A., Wilson, L. J., & Liotta, D. C. (2024) · Organic Process Research & Development · doi:10.1021/acs.oprd.4c00246
Tumor Microenvironment-Responsive Proteolytic Nanodrug against Breast Cancer
Li, T., Zhang, W., Cheng, L., Qian, X., & Zou, J. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c01844
Receptor-Specific Radionuclide Therapy
Lepareur, N., & Bourgeois, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-00773-5_303
Cheng, B., Liu, Y., Xu, Z., Gao, H., Sun, Q., Kong, L., Wang, X., Dai, N., Dong, L., Li, F., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.24.713851
Mechanisms of Tenascin-C dependent tumor angiogenesis
Rupp, T. (2015) · theses.fr (ABES) · doi:10.70675/59851f94zf75az478azb54dza9262a24db92
Moon, D., Kim, D., Balwe, S. G., & Song, J. M. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04354-w
Etude de la reprogrammation métabolique de l' adénocarcinome canalaire pancréatique
Olivares, O. (2015) · theses.fr (ABES) · doi:10.70675/ef2c6a2czab6dz4a68z8004z1ade8605dadc
Rôle du canal TRPM7 dans la prolifération des cellules stellaires pancréatiques humaines activées
Lefebvre, T. (2019) · theses.fr (ABES) · doi:10.70675/674ea5daza64cz4b92z8e11zdbf9b854c481
Fiorino, S., Hong, W., de Biase, D., Mastrangelo, L., Maccioni, F., Grottesi, A., Ambrosi, F., Pincigher, L., Lari, F., Bergamini, C., et al. (2026) · Cancers · doi:10.3390/cancers18121932
Mechanotherapy enhances nanodrug uptake by overcoming the actin cytoskeleton damping effect
Wu, H., Xue, S., Zhao, T., Zhang, H. W., Chen, Y., Yu, J., Huang, Y., Chen, X., Wu, W., Yan, R., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2600686123
Li, T., Xue, J., Li, X., Hao, C., & Zhao, Z. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1914939
Metadata
- Authors
- Kharaishvili, G., Simkova, D., Bouchalova, K., Gachechiladze, M., Narsia, N., & Bouchal, J.
- Affiliations
- Institute of Molecular and Translational Medicine (CZ)
- University of Birmingham (GB)
- Corresponding author
- Bouchal, Jan
- Venue
- Cancer Cell International
- Published
- 2014-05-16
- Volume
- 14
- Issue
- 1
- Pages
- 41-41
- ISSN
- 1475-2867 (ISSN-L)
- PMC
- PMC4038849
- OpenAlex
- W2150704193
- Cited by
- 197
- References
- 110
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 11 · 2023: 12 · 2022: 14 · 2021: 11 · 2020: 8 · 2019: 22 · 2018: 27 · 2017: 19 · 2016: 20 · 2015: 34 · 2014: 3
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Cancer Cell International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- cancer-associated fibroblasts, tumor microenvironment, extracellular matrix stiffness, solid stress, interstitial fluid pressure, treatment resistance, tumor progression, metastasis-initiating cells, stemness, collagen, hyaluronic acid, tumor hypoxia, extracellular pH, neoangiogenesis, immune cells, cytokines, chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
